NASDAQ, PGEN #Private Placement Closed Precigen Announces Closing of Public Offering of Common Stock January 27, 2023 16:05 EST GERMANTOWN, Md., Jan. 27, 2023 /PRNewswire/ — Precigen, Inc. (Nasdaq: PGEN) announced today the closing of its previously announced underwritten public offering of common stock. Precigen sold 42,857,143 shares of its common stock at a public offering price of $1.75 per share. Gross proceeds to Precigen from the offering were No Comments
IKT, NASDAQ #Private Placement Closed #Trending News Inhibikase Therapeutics Announces Closing of $10 Million Concurrent Registered Direct Offering and Private Placement Priced At a Premium to Market Under Nasdaq Rules January 27, 2023 16:05 EST BOSTON and ATLANTA, Jan. 27, 2023 /PRNewswire/ — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease (“PD”), Parkinson’s-related disorders and other diseases of the Abelson Tyrosine Kinases, today announced that it has closed No Comments
NASDAQ, PLRX #New Order #Private Placement Closed #Trending News Pliant Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares January 27, 2023 16:03 EST SOUTH SAN FRANCISCO, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced the closing of its previously announced upsized underwritten public offering of 9,583,334 shares of its common stock, No Comments
JSPR, NASDAQ #New Order #Private Placement Closed #Syndromes Jasper Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares January 27, 2023 13:10 EST REDWOOD CITY, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria and lower to intermediate risk myelodysplastic syndromes (MDS) as well as novel stem cell No Comments
NASDAQ, VMAR #Private Placement Closed Vision Marine Technologies Inc. Announces Closing of Registered Direct Offering January 27, 2023 08:30 EST MONTREAL, Jan. 27, 2023 (GLOBE NEWSWIRE) — Vision Marine Technologies Inc. (NASDAQ: VMAR) (“Vision Marine” or the “Company”), a global leader and innovator within the performance electric recreational boating industry, a global leader and innovator within the performance electric recreational boating industry, today announced the closing of its registered No Comments
OTC, SUUFF #Private Placement Closed Strathmore Announces Closing of Private Placement Financing for Gross Proceeds of $2 Million January 27, 2023 08:30 EST Kelowna, British Columbia–(Newsfile Corp. – January 27, 2023) – Strathmore Plus Uranium (TSXV: SUU) (OTC Pink: SUUFF) (the “Company“) is pleased to report that it has closed its previously announced non-brokered private placement (the “Financing”) for aggregate gross proceeds of $2,000,000 through the issuance of 5,000,000 units (the “Units”) at No Comments
CBUTF, OTC #Private Placement Closed Clear Blue Technologies Closes Final Tranche of Oversubscribed $2.5 Million Private Placement January 27, 2023 07:30 EST NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 27, 2023 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (“Clear Blue” or the “Company”) (TSXV: CBLU), the Smart Off-Grid™ Company, announces that it has closed a second and final tranche of a non-brokered No Comments
OREAF, OTC #Private Placement Closed Orea Announces Closing of Oversubscribed Non-Brokered Private Placement January 26, 2023 13:16 EST VANCOUVER, BC, Jan. 26, 2023 /PRNewswire/ – Orea Mining Corp. (“Orea”) (TSX: OREA) (OTCQB: OREAF) (FSE: 3CG) is pleased to announce that it has closed its non-brokered private placement (the “Private Placement”) previously announced on January 9, 2023. The Private Placement was oversubscribed, raising gross proceeds of CAD$1,056,900 through the No Comments
NASDAQ, VERB, VERBW #Private Placement Closed #Trending News Verb Technology Company, Inc. Closes $7.2 Million Underwritten Public Offering of Common Stock January 26, 2023 09:38 EST NEWPORT BEACH, Calif. and LEHI, Utah, Jan. 26, 2023 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (NASDAQ: VERB) (“VERB” or the “Company”), the leader in interactive video-based sales-enablement applications, including shoppable livestream video, announced the closing of an underwritten public offering with gross proceeds to the Company expected to No Comments
ADYRF, OTC #Private Placement Closed Adyton Resources Corporation Closes Private Placement January 25, 2023 18:49 EST NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. BRISBANE, Australia, Jan. 25, 2023 (GLOBE NEWSWIRE) — Adyton Resources Corporation (TSX Venture: ADY) (“Adyton” or the “Company”) is pleased to announce that it has closed its previously announced CAD $400,000 non-brokered private placement (the No Comments
STEER Announces a Proposed Transaction for an $18 Million Direct Investment Involving its Digital Restaurant Supply Business (B2B Marketplace) 01/23/2023
Ra Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association Congress 01/23/2023